[Topical triamcinolone acetonide in a new combination in the treatment of eczema].
D000777:Anesthetics; D000890:Anti-Infective Agents; D002219:Carbamates / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy*; D004338:Drug Combinations; D004485:Eczema / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D006801:Humans; D006885:Hydroxybutyrates / Q000008:administration & dosage* / Q000009:adverse effects; D011409:Propylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects; D011804:Quinolines / Q000008:administration & dosage* / Q000009:adverse effects; D014222:Triamcinolone Acetonide / Q000008:administration & dosage* / Q000009:adverse effects
D000777:Anesthetics; D000890:Anti-Infective Agents; D002219:Carbamates; D004338:Drug Combinations; D006885:Hydroxybutyrates; D011409:Propylene Glycols; D011804:Quinolines; D014222:Triamcinolone Acetonide
A acetonida de triamcinolona tópica em nova associação no tratamento do eczema.